Figure 2From: Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia Probabilistic sensitivity analysis, which plotted life years gained versus costs for PCV13 and PPSV23 in a cohort of people over 50 years in Colombia, 2012. Back to article page